Alterity Therapeutics Stock (NASDAQ: ATHE) stock price, news, charts, stock research, profile.
Open | $2.080 |
Close | $2.040 |
Volume / Avg. | 54.226K / 80.112K |
Day Range | 2.010 - 2.180 |
52 Wk Range | 1.550 - 5.410 |
Market Cap | $17.897M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 0.59% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alterity Therapeutics (NASDAQ: ATHE) through any online brokerage.
Other companies in Alterity Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN) and Dominari Holdings (NASDAQ:DOMH).
The latest price target for Alterity Therapeutics (NASDAQ: ATHE) was reported by Benchmark on Thursday, March 7, 2024. The analyst firm set a price target for 4.00 expecting ATHE to rise to within 12 months (a possible 95.12% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $2.05 last updated April 19, 2024 at 4:45 PM EDT.
There are no upcoming dividends for Alterity Therapeutics.
Alterity Therapeutics’s Q2 earnings are confirmed for Tuesday, April 30, 2024.
There is no upcoming split for Alterity Therapeutics.
Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.